ZA200806226B - 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrim-idines as jak 2 modulators and methods of use - Google Patents
4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrim-idines as jak 2 modulators and methods of useInfo
- Publication number
- ZA200806226B ZA200806226B ZA200806226A ZA200806226A ZA200806226B ZA 200806226 B ZA200806226 B ZA 200806226B ZA 200806226 A ZA200806226 A ZA 200806226A ZA 200806226 A ZA200806226 A ZA 200806226A ZA 200806226 B ZA200806226 B ZA 200806226B
- Authority
- ZA
- South Africa
- Prior art keywords
- aryl
- idines
- pyrim
- jak
- pyrimidines
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76342606P | 2006-01-30 | 2006-01-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200806226B true ZA200806226B (en) | 2009-09-30 |
Family
ID=40631426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200806226A ZA200806226B (en) | 2006-01-30 | 2008-07-17 | 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrim-idines as jak 2 modulators and methods of use |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101421250A (en) |
ZA (1) | ZA200806226B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9283224B2 (en) * | 2011-04-19 | 2016-03-15 | Nerviano Medical Sciences S.R.L. | Substituted pyrimidinyl-pyrroles active as kinase inhibitors |
TR201911151T4 (en) * | 2013-03-14 | 2019-08-21 | Tolero Pharmaceuticals Inc | Jak2 and alk2 inhibitors and their usage methods. |
CN105377835B (en) * | 2013-07-11 | 2018-08-17 | 贝达药业股份有限公司 | Tyrosine protein kinase conditioning agent and its application process |
CN105399686B (en) * | 2014-09-16 | 2018-05-22 | 深圳微芯生物科技有限责任公司 | Pyrimidine derivatives, its preparation method and its application |
CN105399685B (en) * | 2014-09-16 | 2018-05-22 | 深圳微芯生物科技有限责任公司 | The alternatively preparation method and applications of the heteroaromatic compounds of property JAK3 and/or JAK1 kinase inhibitors |
CN107793417B (en) * | 2016-09-05 | 2020-06-09 | 复旦大学 | Pyrrolo [2,3-d ] pyrimidines and salts thereof, preparation method and medicinal application |
AU2017338853A1 (en) * | 2016-10-04 | 2019-04-18 | Enanta Pharmaceuticals, Inc. | Isoxazole analogs as FXR agonists and methods of use thereof |
JOP20190174B1 (en) * | 2017-01-17 | 2023-09-17 | Astrazeneca Ab | Jak1 selective inhibitors |
CN108794458A (en) * | 2018-07-31 | 2018-11-13 | 湖北欣瑞康医药科技有限公司 | A kind of preparation method of aryl substituted pyrimidine amine acyl derivative |
CN110305140B (en) | 2019-07-30 | 2020-08-04 | 上海勋和医药科技有限公司 | Dihydropyrrolopyrimidines selective JAK2 inhibitors |
CN112142675B (en) * | 2020-10-09 | 2021-11-30 | 嘉兴特科罗生物科技有限公司 | Small molecule compound as JAK kinase inhibitor and application thereof |
CN112375042A (en) * | 2020-10-27 | 2021-02-19 | 安徽医科大学 | Trimethoxy styryl six-membered ring and pyrazolopyrimidine compound, preparation and application thereof |
CN113735859A (en) * | 2021-08-12 | 2021-12-03 | 安徽医科大学 | Kinase inhibitor |
-
2007
- 2007-01-30 CN CNA2007800125077A patent/CN101421250A/en active Pending
-
2008
- 2008-07-17 ZA ZA200806226A patent/ZA200806226B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101421250A (en) | 2009-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200806226B (en) | 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrim-idines as jak 2 modulators and methods of use | |
ZA200802501B (en) | Indenoisoquinolinone analogs and methods of use thereof | |
SI1984353T1 (en) | Aurora kinase modulators and method of use | |
IL196462A0 (en) | Substituted acylanilides and methods of use thereof | |
IL197185A0 (en) | Substituted acylanilides and methods of use thereof | |
IL196956A0 (en) | Aza-benzofuranyl compounds and methods of use | |
HK1126474A1 (en) | Novel pyridopyrazines and their use as modulators of kinases | |
EP2023718A4 (en) | Creatine-ligand compounds and methods of use thereof | |
EP1874759A4 (en) | C-met modulators and methods of use | |
HK1147254A1 (en) | 5-anilinoimidazopyridines and methods of use 5- | |
HK1167140A1 (en) | Aurora kinase modulators and method of use | |
ZA200808017B (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
IL197060A0 (en) | Aza-benzothiophenyl compounds and methods of use | |
EP2021555A4 (en) | Structural element and methods of use thereof | |
IL185309A0 (en) | Isoqunoline compounds and methods of use thereof | |
IL206125A0 (en) | Azaindolizines and methods of use | |
IL192564A0 (en) | Composition and method of use thereof | |
GB0520930D0 (en) | Composition and method of use | |
ZA200806627B (en) | Aurora kinase modulators and method of use | |
ZA201004894B (en) | Nuctraceutical composition and methods of use | |
ZA200803864B (en) | Novel pyridopyrazines and their use as modulators of kinases | |
ZA200900896B (en) | Aza-benzofuranyl compounds and methods of use | |
GB0504657D0 (en) | Compositions and methods of treatment | |
EP2043428A4 (en) | Modulators of rnf5 and uses thereof | |
EP1978999A4 (en) | Isolated mcpip and methods of use |